애널리스트 8명 기준
목표가는 개별 리서치펌 단위가 아닌 시장 컨센서스(평균/최고/최저)입니다. 수집 액션 40건 · 최근 12개월 15건.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 13. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2026. 05. 13. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2026. 05. 13. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 05. 13. | TD Cowen | — | 의견 유지 | Buy → Buy | — | TD Cowen: Buy |
| 2026. 05. 12. | JP Morgan | — | 의견 유지 | Neutral → Neutral | — | JP Morgan: Neutral |
| 2026. 05. 08. | JP Morgan | — | 커버리지 개시 | — → Neutral | — | JP Morgan: Neutral |
| 2026. 05. 05. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2026. 03. 21. | TD Cowen | — | 커버리지 개시 | — → Buy | — | TD Cowen: Buy |
| 2026. 03. 12. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2026. 02. 25. | UBS | — | 커버리지 개시 | — → Buy | — | UBS: Buy |
| 2026. 02. 19. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 02. 18. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 12. 01. | Loop Capital | — | 커버리지 개시 | — → Buy | — | Loop Capital: Buy |
| 2025. 11. 13. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 11. 11. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 08. 14. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 05. 10. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 05. 09. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 05. 08. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 04. 23. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 02. 14. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 02. 14. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 02. 11. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2024. 12. 23. | Northland Capital Markets | — | 의견 유지 | Outperform → Outperform | — | Northland Capital Markets: Outperform |
| 2024. 11. 09. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2024. 11. 09. | Roth MKM | — | 의견 유지 | Buy → Buy | — | Roth MKM: Buy |
| 2024. 10. 31. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2024. 08. 08. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2024. 08. 08. | Roth MKM | — | 투자의견 상향 | Neutral → Buy | — | Roth MKM: Neutral → Buy |
| 2024. 05. 10. | Roth MKM | — | 의견 유지 | Neutral → Neutral | — | Roth MKM: Neutral |
| 2024. 02. 14. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2023. 12. 07. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2023. 08. 11. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2023. 08. 10. | Northland Capital Markets | — | 의견 유지 | Outperform → Outperform | — | Northland Capital Markets: Outperform |
| 2023. 08. 10. | Roth MKM | — | 투자의견 하향 | Buy → Neutral | — | Roth MKM: Buy → Neutral |
| 2023. 08. 10. | Rosenblatt | — | 의견 유지 | Buy → Buy | — | Rosenblatt: Buy |
| 2023. 08. 10. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2023. 05. 11. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2023. 05. 11. | Roth MKM | — | 의견 유지 | — → Buy | — | Roth MKM: Buy |
| 2023. 05. 11. | TD Cowen | — | 의견 유지 | — → Outperform | — | TD Cowen: Outperform |
